Virtual-Integrated Twin for Autonomous Lifesaving (VITAL)

SOL #: DARPA-PS-26-26Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Advanced Research Projects Agency (Darpa)
DEF ADVANCED RESEARCH PROJECTS AGCY
ARLINGTON, VA, 222032114, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

National Defense R&D Services; Department Of Defense Military; Applied Research (AC12)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 9, 2026
2
Submission Deadline
Jun 25, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative approaches for its Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) program. This initiative aims to develop continuously updating digital twin models of the cardiovascular system to simulate interventions and predict outcomes in real-time, shifting medical care from reactive to anticipatory. Multiple Other Transaction for Prototype agreements are anticipated.

Program Scope & Objectives

The VITAL program seeks to establish a foundation for causal, prediction-driven decision support in medicine. Key objectives include:

  • Developing High Fidelity (HF) digital twin models representing underlying physical, biochemical, and anatomical dynamics.
  • Creating Reduced Order Models (ROMs) suitable for real-time responsiveness and continuous updating, derived from HF models.
  • Integrating HF and ROM models into a pipeline for intervention simulation and prediction.
  • Continuously validating models to establish bounds of physiological modeling.
  • Focusing on either chronic conditions (e.g., heart failure) or acute perturbations (e.g., hemorrhagic shock).

Contract Details & Timeline

  • Contract Type: Other Transaction for Prototype agreements.
  • Anticipated Awards: Multiple awards.
  • Period of Performance: 36 months (Phase 1: 15 months, Phase 2: 21 months).
  • Published Date: April 9, 2026
  • Questions Due: April 23, 2026, 12:00 PM ET
  • Abstract Submission Deadline: May 20, 2026, 5:00 PM ET
  • OPP Package Questions Due (Anticipated): June 23, 2026
  • OPP Package Submission Due (Anticipated): July 10, 2026
  • Oral Presentation Date (Anticipated): July 23, 2026

Eligibility & Set-Aside

  • Eligibility: Open to all responsible sources, including large and small businesses, non-traditional defense contractors, universities, and research institutions.
  • Set-Aside: None specified.

Submission & Evaluation

Proposers must first submit an abstract. Successful abstract submissions may lead to an invitation to submit an Oral Presentation Proposal (OPP) package and participate in oral presentations.

  • Abstract Evaluation: Based on Technical Approach, Technical Ability, and Budget.
  • OPP Evaluation (Descending Order): Technical Approach, Relevant Qualifications, Budget, Data Rights.
  • Submission Method: Abstracts and OPPs via DARPA’s Broad Agency Announcement Tool (BAAT).
  • Required Attachments: Abstract Summary Slide Template, Abstract Instructions and Template, and Oral Presentation Proposal (OPP) Package Guidance.

Contact Information

  • Primary Contact: Dr. Roozbeh Jafari, Program Manager, DARPA/BTO
  • Email: VITAL@darpa.mil

People

Points of Contact

Dr. Roozbeh Jafari, Program Manager, DARPA/BTOPRIMARY

Files

Files

Download
Download
Download
Download

Versions

Version 1Viewing
Solicitation
Posted: Apr 9, 2026
Virtual-Integrated Twin for Autonomous Lifesaving (VITAL) | GovScope